Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Business Of Biotech
00:00
The Importance of Basic Science in Emerging and Clinical Stage Biopharma
The transition from academia to industry can feel a little bit unnatural. How have you leaned into your academic leadership to sort of inform the way that you lead emerging and clinical stage biopharma? The answer is very simple. I think that basic science is absolutely extremely important for giving good grounds to any type of practical or industrial development.
Transcript
Play full episode
